-
admin
Posts
Rogers to Offer All-New iPhone 16, iPhone 16 Plus, iPhone 16 Pro, iPhone 16 Pro Max, Apple Watch Series 10, Apple Watch Ultra 2 in Black Titanium, and AirPods 4
The iPhone 16 lineup is available to pre-order starting on Friday, September 13, and Apple Watch Series 10, Apple Watch Ultra 2 in black titanium,...
PodcastOne (Nasdaq: PODC) Acquires Exclusive Multi-Year Sales and Distribution Rights to Fool Coverage with Manny MUA and Laura Lee Podcast
Fool Coverage Has 153 Episodes Since Its Launch in 2021 17th New Podcast Joining PodcastOne Network This Fiscal Year, 45th in Last 12 Months 3.8...
Hisummer Launches in the U.S: Bringing Warmth and Innovation to Modern Homes
LOS ANGELES, Sept. 13, 2024 (GLOBE NEWSWIRE) — Hisummer, a new brand dedicated to blending modern technology with home comfort, is excited to announce its...
Vhernier announces key leadership changes
13 SEPTEMBER 2024 VHERNIER ANNOUNCES KEY LEADERSHIP CHANGES Following the completion of Vhernier’s acquisition by leading luxury goods group Richemont, the Maison is pleased...
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Sept. 13, 2024 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving...
Tr1X to Participate at Upcoming Healthcare Investment Conferences
SAN DIEGO, Sept. 13, 2024 (GLOBE NEWSWIRE) — Tr1X, Inc. (pronounced “Trix”), a biopharmaceutical company specializing in allogeneic engineered Treg and CAR-Treg cell therapies with...
KFSHRC Pioneering Ethical Innovation in Global Healthcare
RIYADH, Saudi Arabia, Sept. 13, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSHRC) has reiterated its commitment to ethical innovation in...
MetasTx Welcomes Esteemed Cancer Scientist Dr. Jonathan Chernoff to the Board of Managers
Renowned Cancer Researcher Brings Deep Expertise to Accelerate MetasTx’s Mission to Combat Metastatic Cancer PHILADELPHIA, Sept. 13, 2024 (GLOBE NEWSWIRE) — MetasTx, a pioneering biopharmaceutical...
ONL Therapeutics Closes $65 Million in Oversubscribed Series D Financing
Funds will advance the development of ONL1204 Ophthalmic Solution with the initiation of a Phase 2 global study for the treatment of geographic atrophy (GA)...
111 Inc. Announces Its Co-founders’ Strategic Share Purchase and Highlights Continued Growth and Innovation
SHANGHAI, Sept. 13, 2024 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value...